Impact of Anticoagulation on Mortality and Resource Utilization Among Critically Ill Patients With Major Bleeding

被引:14
|
作者
Fernando, Shannon M. [1 ,2 ]
Mok, Garrick [2 ]
Castellucci, Lana A. [3 ,4 ]
Dowlatshahi, Dar [4 ,5 ,6 ]
Rochwerg, Bram [7 ,8 ]
McIsaac, Daniel I. [4 ,5 ,9 ]
Carrier, Marc [3 ,4 ]
Wells, Philip S. [3 ,4 ]
Bagshaw, Sean M. [10 ]
Fergusson, Dean A. [4 ,5 ]
Tanuseputro, Peter [4 ,5 ,11 ]
Kyeremanteng, Kwadwo [1 ,5 ,11 ]
机构
[1] Univ Ottawa, Dept Med, Div Crit Care, Ottawa, ON, Canada
[2] Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada
[3] Univ Ottawa, Dept Med, Div Hematol, Ottawa, ON, Canada
[4] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada
[5] Ottawa Hosp Res Inst, Clin Epidmiol Program, Ottawa, ON, Canada
[6] Univ Ottawa, Dept Med, Div Neurol, Ottawa, ON, Canada
[7] McMaster Univ, Div Crit Care, Dept Med, Hamilton, ON, Canada
[8] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[9] Univ Ottawa, Dept Anesthesiol & Pain Med, Ottawa, ON, Canada
[10] Univ Alberta, Fac Med & Dent, Dept Crit Care Med, Edmonton, AB, Canada
[11] Univ Ottawa, Dept Med, Div Palliat Care, Ottawa, ON, Canada
关键词
anticoagulation; costs; gastrointestinal bleeding; intensive care unit; intracranial hemorrhage; major bleeding; VENOUS THROMBOEMBOLISM; ORAL ANTICOAGULANTS; ATRIAL-FIBRILLATION; INTENSIVE-CARE; ANTITHROMBOTIC THERAPY; WARFARIN; MULTICENTER; MANAGEMENT; HEMORRHAGE; COSTS;
D O I
10.1097/CCM.0000000000004206
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: Patients with major bleeding are commonly admitted to the ICU. A growing number are on either oral or parenteral anticoagulation, but the impact of anticoagulation on patient outcomes is unknown. We sought to examine this association between anticoagulation therapy and mortality, as well as the independent effects of warfarin compared to direct oral anticoagulants. Design: Analysis of a prospectively collected registry (2011-2017) of consecutive ICU patients admitted with major bleeding (as defined by International Society on Thrombosis and Haemostasis clinical criteria). Setting: Two hospitals within a single tertiary care level hospital system. Patients: We analyzed 1,598 patients identified with major bleeding, of which 245 (15.3%) had been using anticoagulation at the time of ICU admission. Of patients on anticoagulation, 149 were using warfarin, and 60 were using a direct oral anticoagulant. Interventions: None. Measurements and Main Results: The primary outcome, in-hospital mortality, was analyzed using a multivariable logistic regression model. Patients with anticoagulation-associated major bleeding had higher in-hospital mortality (adjusted odds ratio, 1.49; 95% CI, 1.16-1.92). Among survivors, anticoagulation use was associated with longer median hospital length of stay, and higher mean costs. No differences in hospital mortality were seen between warfarin- and direct oral anticoagulant-associated major bleeding. Patients with warfarin-associated major bleeding had longer median length of stay (11 vs 6 d; p = 0.02), and higher total costs than patients with direct oral anticoagulant-associated major bleeding. Conclusions: Among ICU patients admitted with major bleeding, pre-admission anticoagulation use was associated with increased hospital mortality, prolonged length of stay, and higher costs among survivors. As compared to direct oral anticoagulants, patients with warfarin-associated major bleeding had increased length of stay and costs. These findings have important implications in the care of ICU patients with major bleeding.
引用
收藏
页码:515 / 524
页数:10
相关论文
共 50 条
  • [1] Resource Utilization for Gastrointestinal Bleeding in Critically Ill Patients with COVID-19 Pneumonia
    Garcia, Glenn
    Lake, Alexander
    Blas, Jacqueline
    Padrino, Nicholle
    Perez, Rosa Diaz
    Rangroo, Rohit
    Sorresso, Domenick
    Thakore, Shaival
    Staffetti, Joseph
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S472 - S473
  • [2] Delayed Major Bleeding in Critically Ill Trauma Patients
    Castellucci, Lana A.
    Shaw, Joseph
    Le Gal, Gregoire
    Hawken, Stephen
    McIntyre, Lauralyn
    Carrier, Marc
    [J]. BLOOD, 2015, 126 (23)
  • [3] Risk of Major Bleeding Associated with Aspirin Use in Critically Ill Medical Patients Receiving Therapeutic Anticoagulation
    Subat, Y.
    Rayes, H. A. A.
    Evans, K.
    Weister, T. J.
    Kashyap, R.
    Gajic, O.
    Warner, M. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [4] ANTICOAGULATION, BLEEDING, AND IMMUNOTHROMBOSIS IN CRITICALLY ILL PATIENTS WITH COVID-19
    Vargas, Juan Paez
    Gonzalez, Anxela Vidal
    Robaglia, Denis
    Piris, Miguel
    Alen, Jose Fortes
    Gorgolas, Miguel
    Llamas, Pilar
    Calvo, Cesar Perez
    Flandes, Javier
    Prieto-Perez, Laura
    [J]. CHEST, 2021, 160 (04) : 994A - 995A
  • [5] Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis
    François Lauzier
    Donald M. Arnold
    Christian Rabbat
    Diane Heels-Ansdell
    Ryan Zarychanski
    Peter Dodek
    Betty Jean Ashley
    Martin Albert
    Kosar Khwaja
    Marlies Ostermann
    Yoanna Skrobik
    Robert Fowler
    Lauralyn McIntyre
    Joseph L. Nates
    Tim Karachi
    Renato D. Lopes
    Nicole Zytaruk
    Simon Finfer
    Mark Crowther
    Deborah Cook
    [J]. Intensive Care Medicine, 2013, 39 : 2135 - 2143
  • [6] Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis
    Lauzier, Francois
    Arnold, Donald M.
    Rabbat, Christian
    Heels-Ansdell, Diane
    Zarychanski, Ryan
    Dodek, Peter
    Ashley, Betty Jean
    Albert, Martin
    Khwaja, Kosar
    Ostermann, Marlies
    Skrobik, Yoanna
    Fowler, Robert
    McIntyre, Lauralyn
    Nates, Joseph L.
    Karachi, Tim
    Lopes, Renato D.
    Zytaruk, Nicole
    Finfer, Simon
    Crowther, Mark
    Cook, Deborah
    [J]. INTENSIVE CARE MEDICINE, 2013, 39 (12) : 2135 - 2143
  • [7] Coagulation Parameters and Major Bleeding in Critically Ill Patients With Cirrhosis
    Drolz, Andreas
    Horvatits, Thomas
    Roedl, Kevin
    Rutter, Karoline
    Staufer, Katharina
    Kneidinger, Nikolaus
    Holzinger, Ulrike
    Zauner, Christian
    Schellongowski, Peter
    Heinz, Gottfried
    Perkmann, Thomas
    Kluge, Stefan
    Trauner, Michael
    Fuhrmann, Valentin
    [J]. HEPATOLOGY, 2016, 64 (02) : 556 - 568
  • [8] Risk of major bleeding associated with aspirin use in non-surgical critically ill patients receiving therapeutic anticoagulation
    Subat, Yosuf W.
    Rayes, Hamza
    Hanson, Andrew C.
    Johnson, Madeline Q.
    Schulte, Phillip J.
    Evans, Kimberly
    Weister, Timothy
    Trivedi, Vrinda
    Gajic, Ognjen
    Warner, Matthew A.
    [J]. JOURNAL OF CRITICAL CARE, 2020, 58 : 34 - 40
  • [9] Argatroban anticoagulation in critically ill patients
    Beiderlinden, Martin
    Treschan, Tanja A.
    Goerlinger, Klaus
    Peters, Juergen
    [J]. ANNALS OF PHARMACOTHERAPY, 2007, 41 (05) : 749 - 754
  • [10] Blood transfusions and mortality among critically ill patients
    Karkouti, K
    Beattie, WS
    Wijeysundera, DN
    McCluskey, SA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (10): : 1242 - 1242